Gene and cell therapies to combat pancreatic cancer

byMary Ann Liebert, IncGTMP clinical trials for pancreatic cancer depending on phase and trial status. Source: Clinical trial.gov. GTMPs, gene therapy medicinal products. Credit:Human Gene

Updated on: December 25,2023

Gene and cell therapies to combat pancreatic cancer

byMary Ann Liebert, IncGTMP clinical trials for pancreatic cancer depending on phase and trial status. Source: Clinical trial.gov. GTMPs, gene therapy medicinal products. Credit:Human Gene

Updated on:December 25,2023

Breast cancer awareness campaigns too often overlook those with metastatic breast cancer. Here's how they can do better

by Rachel Kraus,The ConversationCredit: Unsplash/CC0 Public DomainIs there anyone who isn't aware of breast cancer?Since 1985, cancer-related nonprofits, along with pharmaceutical firms and

Updated on: January 02,2024

Breast cancer awareness campaigns too often overlook those with metastatic breast cancer. Here's how they can do better

by Rachel Kraus,The ConversationCredit: Unsplash/CC0 Public DomainIs there anyone who isn't aware of breast cancer?Since 1985, cancer-related nonprofits, along with pharmaceutical firms and

Updated on:January 02,2024

Chemotherapy could increase disease susceptibility in future generations

byWashington State UniversityCredit: Unsplash/CC0 Public DomainA common chemotherapy drug could carry a toxic inheritance for children and grandchildren of adolescent cancer survivors, Washingto

Updated on: December 25,2023

Chemotherapy could increase disease susceptibility in future generations

byWashington State UniversityCredit: Unsplash/CC0 Public DomainA common chemotherapy drug could carry a toxic inheritance for children and grandchildren of adolescent cancer survivors, Washingto

Updated on:December 25,2023

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre

Updated on: July 08,2024

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre

Updated on:July 08,2024

Cryoablation found highly effective for breast cancer patients with large tumors

by The Reis GroupMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA minimally invasive technique that uses ice to freeze and destroy small, cancerous tu

Updated on: March 30,2024

Cryoablation found highly effective for breast cancer patients with large tumors

by The Reis GroupMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA minimally invasive technique that uses ice to freeze and destroy small, cancerous tu

Updated on:March 30,2024

Updates: MET targeted therapy for EXON 14 mutations in lung cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainAnew editorial papertitled "Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer" has been published

Updated on: March 21,2024

Updates: MET targeted therapy for EXON 14 mutations in lung cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainAnew editorial papertitled "Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer" has been published

Updated on:March 21,2024

Researchers create a drug to extend the lives of men with prostate cancer

by Stuart Wolpert,University of California, Los AngelesMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Fifteen ye

Updated on: June 24,2024

Researchers create a drug to extend the lives of men with prostate cancer

by Stuart Wolpert,University of California, Los AngelesMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Fifteen ye

Updated on:June 24,2024

Trial finds adding immunotherapy to neoadjuvant chemoradiation may improve outcomes in esophageal cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA studypublishedinClinical Cancer Researchfound that in patients with unresectable, locally advanced

Updated on: November 30,2024

Trial finds adding immunotherapy to neoadjuvant chemoradiation may improve outcomes in esophageal cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA studypublishedinClinical Cancer Researchfound that in patients with unresectable, locally advanced

Updated on:November 30,2024

American Cancer Society issues nutrition, exercise guidelines for cancer survivors

In a guideline issued by the American Cancer Society and published in the May/June issue ofCA: A Cancer Journal for Clinicians, recommendations are presented regarding diet and exercise for redu

Updated on: December 28,2023

American Cancer Society issues nutrition, exercise guidelines for cancer survivors

In a guideline issued by the American Cancer Society and published in the May/June issue ofCA: A Cancer Journal for Clinicians, recommendations are presented regarding diet and exercise for redu

Updated on:December 28,2023

The role of p53 as a target for novel cancer therapies

by Erika Rindsjö,Karolinska InstitutetComplex interplay between TP53-mutant cancer cells and their microenvironment. Credit:Nature Reviews Clinical Oncology(2023). DOI: 10.1038/s4157

Updated on: December 30,2023

The role of p53 as a target for novel cancer therapies

by Erika Rindsjö,Karolinska InstitutetComplex interplay between TP53-mutant cancer cells and their microenvironment. Credit:Nature Reviews Clinical Oncology(2023). DOI: 10.1038/s4157

Updated on:December 30,2023

First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

by Perelman School of Medicine at the University of PennsylvaniaSafety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with

Updated on: January 26,2024

First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

by Perelman School of Medicine at the University of PennsylvaniaSafety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with

Updated on:January 26,2024

The new prostate cancer blood test with 94 per cent accuracy

byUniversity of East AngliaProstate cancer cells. Credit: NIH Image GalleryResearchers at the University of East Anglia have helped develop a new blood test to detect prostate cancer with greate

Updated on: January 12,2024

The new prostate cancer blood test with 94 per cent accuracy

byUniversity of East AngliaProstate cancer cells. Credit: NIH Image GalleryResearchers at the University of East Anglia have helped develop a new blood test to detect prostate cancer with greate

Updated on:January 12,2024